MGRX · Mangoceuticals Inc
United States · RS rating 10 · As of 2026-10-14
| Price | 0.33 USD |
|---|---|
| 1-day change | -11.9% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 10 / 24 / 4 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 22 / 38 |
| Industry group (rank) | Medical-Generic Drugs (94) |
| EPS growth Q/Q | +59.1% |
| Sales growth Q/Q | +12.0% |
| Distance from 52-week high | +88.0% |
| Market cap (USD) | $6.9M |